The Association between Serum Levels of 25[OH]D, Body Weight Changes and Body Composition Indices in Patients with Heart Failure.

25[OH]D body wasting heart failure metabolic instability weight change

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
24 Apr 2020
Historique:
received: 03 04 2020
revised: 19 04 2020
accepted: 21 04 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 30 4 2020
Statut: epublish

Résumé

We try to determine the association between weight changes (WC), both loss or gain, body composition indices (BCI) and serum levels of 25[OH]D during heart failure (HF). WC was determined in 412 patients (14.3% female, aged: 53.6 ± 10.0 years, NYHA class: 2.5 ± 0.8). Body fat, fat percentage and fat-free mass determined by dual energy X-rays absorptiometry (DEXA) and serum levels of 25[OH]D were analyzed. Logistic regression was used to calculate odds ratios for 25[OH]D insufficiency (<30 ng/mL) or deficiency (<20 ng/mL) by quintiles of WC, in comparison to weight-stable subgroup. The serum 25[OH]D was lower in weight loosing than weight stable subgroup. In fully adjusted models the risk of either insufficient or deficient 25[OH]D levels was independent of BCI and HF severity markers. The risk was elevated in higher weight loss subgroups but also in weight gain subgroup. In full adjustment, the odds for 25[OH]D deficiency in the top weight loss and weight gain subgroups were 3.30; 95%CI: 1.37-7.93,

Identifiants

pubmed: 32344712
pii: jcm9041228
doi: 10.3390/jcm9041228
pmc: PMC7231116
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Endocrinology. 2014 Sep;155(9):3227-37
pubmed: 24949660
Kardiol Pol. 2014;72(1):56-63
pubmed: 23990230
J Clin Endocrinol Metab. 2012 Apr;97(4):1153-8
pubmed: 22442274
Am J Cardiol. 2004 Apr 22;93(8A):41A-43A
pubmed: 15094105
Am Heart J. 2013 Aug;166(2):357-364.e2
pubmed: 23895820
Endocrine. 2017 Dec;58(3):574-581
pubmed: 28337657
Br J Nutr. 2012 Dec 14;108(11):1915-23
pubmed: 23046765
Int J Cardiol. 2013 Jan 10;162(2):77-85
pubmed: 21982619
Eur J Appl Physiol. 2019 Apr;119(4):825-839
pubmed: 30830277
Exerc Sport Sci Rev. 2014 Apr;42(2):76-81
pubmed: 24508736
Endocrinology. 2009 Feb;150(2):651-61
pubmed: 18845643
Eur J Heart Fail. 2012 Apr;14(4):357-66
pubmed: 22308011
Osteoporos Int. 2009 Mar;20(3):417-25
pubmed: 18629568
Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E820-8
pubmed: 19176352
Sci Rep. 2018 Jan 18;8(1):1169
pubmed: 29348609
J Bone Miner Res. 2004 Feb;19(2):265-9
pubmed: 14969396
Endocrinology. 2014 Feb;155(2):347-57
pubmed: 24280059
J Clin Endocrinol Metab. 2011 May;96(5):1560-7
pubmed: 21367931
Stem Cell Res Ther. 2016 Aug 17;7(1):118
pubmed: 27530414
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):135-145
pubmed: 21475703
J Clin Endocrinol Metab. 2013 Dec;98(12):E1927-35
pubmed: 24108316
Front Physiol. 2014 Jul 11;5:248
pubmed: 25071593
Endocrinology. 2003 Dec;144(12):5138-44
pubmed: 12959989
Int J Cardiol. 2018 Feb 15;253:84-90
pubmed: 29306478
Pharmacol Ther. 2009 Mar;121(3):227-52
pubmed: 19061914
Am J Physiol Cell Physiol. 2012 Aug 15;303(4):C396-405
pubmed: 22648952
J Clin Lab Anal. 2013 Jul;27(4):284-9
pubmed: 23852785
Front Physiol. 2014 Jul 02;5:244
pubmed: 25071589
Nutrients. 2016 Aug 30;8(9):
pubmed: 27589793
Am Heart J. 2010 Nov;160(5):893-9
pubmed: 21095277
Nat Rev Endocrinol. 2014 Feb;10(2):79-87
pubmed: 24247221
Curr Probl Cardiol. 2019 Mar 28;:100417
pubmed: 31036371
Eur J Heart Fail. 2008 Mar;10(3):321-7
pubmed: 18304873
Eur J Epidemiol. 2014 Mar;29(3):199-210
pubmed: 24682834
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):333-42
pubmed: 27219044
Physiol Rev. 2016 Jan;96(1):365-408
pubmed: 26681795
Nutr Hosp. 2005 Jan-Feb;20(1):38-45
pubmed: 15762418
Public Health Nutr. 2015 Jan;18(1):112-21
pubmed: 24476931
Lancet. 2003 Mar 29;361(9363):1077-83
pubmed: 12672310
J Clin Endocrinol Metab. 2008 Oct;93(10):3927-35
pubmed: 18682515
Clin Sci. 1972 Sep;43(3):413-31
pubmed: 4342673
J Biol Chem. 2011 Sep 30;286(39):33804-10
pubmed: 21840998
J Clin Endocrinol Metab. 2012 Oct;97(10):3700-8
pubmed: 22802085
J Endocrinol Invest. 2020 Mar 5;:
pubmed: 32140858

Auteurs

Apolonia Stefaniak (A)

Department of Toxicology and Health Protection, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Robert Partyka (R)

Clinical Division of Anesthesiology and Intensive Therapy of the Department of Anesthesiology, Intensive Treatment and Emergency Medicine, Medical University of Silesia, 41-800 Zabrze, Poland.

Sylwia Duda (S)

Department of Toxicology and Health Protection, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Weronika Ostręga (W)

Department of Toxicology and Health Protection, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Jacek Niedziela (J)

Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Silesian Centre for Heart Disease, 41-800 Zabrze, Poland.

Jolanta Nowak (J)

Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Silesian Centre for Heart Disease, 41-800 Zabrze, Poland.

Jolanta Malinowska-Borowska (J)

Department of Toxicology and Health Protection, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Tomasz Rywik (T)

Heart Failure and Transplantology Department The Cardinal Stefan Wyszynski Institute of Cardiology, 04-628 Warsaw, Poland.

Przemysław Leszek (P)

Heart Failure and Transplantology Department The Cardinal Stefan Wyszynski Institute of Cardiology, 04-628 Warsaw, Poland.

Bartosz Hudzik (B)

Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Silesian Centre for Heart Disease, 41-800 Zabrze, Poland.
Department of Cardiovascular Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Barbara Zubelewicz-Szkodzińska (B)

Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

Piotr Rozentryt (P)

Department of Toxicology and Health Protection, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.
Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Silesian Centre for Heart Disease, 41-800 Zabrze, Poland.

Classifications MeSH